41.8 F
Fort Worth
Thursday, October 29, 2020
Government Senators scrutinize Mylan over EpiPen's price increases

Senators scrutinize Mylan over EpiPen’s price increases

Other News

Exxon’s oil slick

Exxon Mobil is slashing its capital spending budget for 2020 by 30% due to weak demand caused by the COVID-19 pandemic and a market...

Folk music’s Mark Twain: 7 Essential tracks from John Prine,

NEW YORK (AP) — Some people, the songs just come out of them. For nearly half a century, they tumbled out of John Prine...

Tarrant County records another COVID-19 death

Tarrant County Public Health (TCPH) on Wednesday, April 8 reported that a resident of Euless has died as the result of the COVID-19 virus....

Tradition stymied: A year unlike any since WWII for Augusta

The Masters is so intertwined with Augusta, they added an extra day to spring break.You see, the first full week of April isn't just...

Two senior U.S. senators are examining Mylan’s price increases for the popular EpiPen allergy shot, with one Republican saying the drugmaker’s practices may have limited access to the treatment.

Sen. Charles Grassley, R-Iowa, asked the drugmaker to explain “a steep price increase in the product in recent years,” citing complaints from constituents who say they have to pay as much as $500 for one of the pens. Grassley heads the Senate Committee on the Judiciary.

“The substantial price increase could limit access to a much-needed medication,” Grassley wrote to Mylan Chief Executive officer Heather Bresch in an Aug. 22 letter.

In a separate letter Monday, Sen. Amy Klobuchar, D-Minnesota, asked the Federal Trade Commission to investigate Mylan’s practices with regards to EpiPen’s price. She called for the FTC to look into whether Mylan had done anything to deny competitors access to the market in order to keep raising prices.

EpiPen is a self-administered injection of epinephrine, a drug that can be used to treat allergic reactions from bee stings, food allergies or other triggers. Since acquiring the drug in 2007, Mylan has raised the price several times, up from about $57 a shot when it first took over sales of the product, a review of pricing data by Bloomberg found.

Mylan spokeswoman Nina Devlin declined to comment specifically on the letters. The company says that it offers several programs to help people afford the drug.

“Ensuring access to epinephrine — the only first-line treatment for anaphylaxis — is a core part of our mission.

Latest News

FBI warns ransomware assault threatens US healthcare system

By FRANK BAJAK AP Technology WriterBOSTON (AP) — Federal agencies warned that cybercriminals are unleashing a wave of data-scrambling extortion attempts against...

Tarrant County indicts 4 for elder fraud

The Tarrant County Criminal District Attorney's Office announced Wednesday that three men and one woman have been indicted on charges of engaging...

Former DHS official says he wrote ‘Anonymous’ Trump critique

By KEVIN FREKING and ZEKE MILLER Associated PressWASHINGTON (AP) — A former Trump administration official who penned a scathing anti-Trump op-ed and...

Developer tied to Texas AG accused judge, others of fraud

By JAKE BLEIBERG Associated PressDALLAS (AP) — An Austin real estate developer at the center of recent allegations against Texas Attorney General...

AP Explains: The rule that made the modern internet

By BARBARA ORTUTAY AP Technology Writer OAKLAND, Calif. (AP) — Twenty-six words tucked into a 1996 law overhauling telecommunications...